The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome

Peptides play a seminal role in most physiological processes acting as neurotransmitters, hormones, antibiotics, and immune regulation. In the context of tumor biology, it is hypothesized that endogenous peptides, hormones, cytokines, growth factors, and aberrant degradation of select protein networ...

Full description

Saved in:
Bibliographic Details
Published inThe Enzymes Vol. 42; p. 27
Main Authors Greening, David W, Kapp, Eugene A, Simpson, Richard J
Format Journal Article
LanguageEnglish
Published United States 2017
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Peptides play a seminal role in most physiological processes acting as neurotransmitters, hormones, antibiotics, and immune regulation. In the context of tumor biology, it is hypothesized that endogenous peptides, hormones, cytokines, growth factors, and aberrant degradation of select protein networks (e.g., enzymatic activities, protein shedding, and extracellular matrix remodeling) are fundamental in mediating cancer progression. Analysis of peptides in biological fluids by mass spectrometry holds promise of providing sensitive and specific diagnostic and prognostic information for cancer and other diseases. The identification of circulating peptides in the context of disease constitutes a hitherto source of new clinical biomarkers. The field of peptidomics can be defined as the identification and comprehensive analysis of physiological and pathological peptides. Like proteomics, peptidomics has been advanced by the development of new separation strategies, analytical detection methods such as mass spectrometry, and bioinformatic technologies. Unlike proteomics, peptidomics is targeted toward identifying endogenous protein and peptide fragments, defining proteolytic enzyme substrate specificity, as well as protease cleavage recognition (degradome). Peptidomics employs "top-down proteomics" strategies where mass spectrometry is applied at the proteoform level to analyze intact proteins and large endogenous peptide fragments. With recent advances in prefractionation workflows for separating peptides, mass spectrometry instrumentation, and informatics, peptidomics is an important field that promises to impact on translational medicine. This review covers the current advances in peptidomics, including top-down and imaging mass spectrometry, comprehensive quantitative peptidome analyses (developments in reproducibility and coverage), peptide prefractionation and enrichment workflows, peptidomic data analyses, and informatic tools. The application of peptidomics in cancer biomarker discovery will be discussed.
AbstractList Peptides play a seminal role in most physiological processes acting as neurotransmitters, hormones, antibiotics, and immune regulation. In the context of tumor biology, it is hypothesized that endogenous peptides, hormones, cytokines, growth factors, and aberrant degradation of select protein networks (e.g., enzymatic activities, protein shedding, and extracellular matrix remodeling) are fundamental in mediating cancer progression. Analysis of peptides in biological fluids by mass spectrometry holds promise of providing sensitive and specific diagnostic and prognostic information for cancer and other diseases. The identification of circulating peptides in the context of disease constitutes a hitherto source of new clinical biomarkers. The field of peptidomics can be defined as the identification and comprehensive analysis of physiological and pathological peptides. Like proteomics, peptidomics has been advanced by the development of new separation strategies, analytical detection methods such as mass spectrometry, and bioinformatic technologies. Unlike proteomics, peptidomics is targeted toward identifying endogenous protein and peptide fragments, defining proteolytic enzyme substrate specificity, as well as protease cleavage recognition (degradome). Peptidomics employs "top-down proteomics" strategies where mass spectrometry is applied at the proteoform level to analyze intact proteins and large endogenous peptide fragments. With recent advances in prefractionation workflows for separating peptides, mass spectrometry instrumentation, and informatics, peptidomics is an important field that promises to impact on translational medicine. This review covers the current advances in peptidomics, including top-down and imaging mass spectrometry, comprehensive quantitative peptidome analyses (developments in reproducibility and coverage), peptide prefractionation and enrichment workflows, peptidomic data analyses, and informatic tools. The application of peptidomics in cancer biomarker discovery will be discussed.
Author Greening, David W
Simpson, Richard J
Kapp, Eugene A
Author_xml – sequence: 1
  givenname: David W
  surname: Greening
  fullname: Greening, David W
  email: d.greening@latrobe.edu.au
  organization: La Trobe Institute for Molecular Science (LIMS), La Trobe University, Melbourne, Victoria, Australia. Electronic address: d.greening@latrobe.edu.au
– sequence: 2
  givenname: Eugene A
  surname: Kapp
  fullname: Kapp, Eugene A
  organization: Systems Biology & Personalised Medicine Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Florey Institute of Neuroscience, Parkville, Victoria, Australia; University of Melbourne, Parkville, Victoria, Australia
– sequence: 3
  givenname: Richard J
  surname: Simpson
  fullname: Simpson, Richard J
  email: richard.simpson@latrobe.edu.au
  organization: La Trobe Institute for Molecular Science (LIMS), La Trobe University, Melbourne, Victoria, Australia. Electronic address: richard.simpson@latrobe.edu.au
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29054270$$D View this record in MEDLINE/PubMed
BookMark eNpFj8tOwzAURL0ooqX0B1gg_0DC9SN2zK5EvKQikCjryo5v2khtEtnuonw9QYDYzEijmSPNBZl0fYeEXDHIGTB142KO3WfOgekcyhxATMgMJBcZV6CnZBFj6wC4NEwYfU6m3EAhuYYZ2a13SN9wSK3vD0irUSLtG7rc4i19sTHS9wHrFMY8hVN2ZyN6Wu1ssHXC0H7a1Pbd9yCNnKoN9XE_Rt2WVrarMfyjL8lZY_cRF78-Jx8P9-vqKVu9Pj5Xy1VWc8lS5jX3kjknNRaFsMiZMY0WpbC2aFAwXgpVNrVTyo195UEqkNKVxhsJWik-J9c_3OHoDug3Q2gPNpw2f5f5F8lmWi8
CitedBy_id crossref_primary_10_1002_biof_1875
crossref_primary_10_1186_s12014_019_9243_3
crossref_primary_10_1007_s00251_018_1093_z
crossref_primary_10_1016_j_isci_2024_109005
crossref_primary_10_3390_jof9010063
crossref_primary_10_3390_ijms22115940
crossref_primary_10_1016_j_jhepr_2020_100115
crossref_primary_10_1016_j_mbplus_2022_100127
crossref_primary_10_1002_prca_201800138
crossref_primary_10_1002_prca_202100097
crossref_primary_10_1038_s41598_023_36867_x
crossref_primary_10_1016_j_clinbiochem_2020_02_010
crossref_primary_10_1515_cclm_2021_0713
crossref_primary_10_1007_s10989_023_10573_8
crossref_primary_10_1021_acs_jproteome_1c00295
crossref_primary_10_1002_jdn_10279
ContentType Journal Article
Copyright 2017 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2017 Elsevier Inc. All rights reserved.
DBID NPM
DOI 10.1016/bs.enz.2017.08.003
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
ExternalDocumentID 29054270
Genre Journal Article
GroupedDBID MVM
NPM
ID FETCH-LOGICAL-c241t-d72d41bb47e553ae2199f7383aa5fe3128368fcb66b2416d046044b89d9407662
ISSN 0423-2607
IngestDate Wed Oct 16 00:49:57 EDT 2024
IsPeerReviewed false
IsScholarly true
Keywords Peptides
Proteolysis
Proteomics
Biomarkers
Top-down proteomics
Informatics
Mass spectrometry
Cancer
Peptidome
Language English
License 2017 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c241t-d72d41bb47e553ae2199f7383aa5fe3128368fcb66b2416d046044b89d9407662
PMID 29054270
ParticipantIDs pubmed_primary_29054270
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Enzymes
PublicationTitleAlternate Enzymes
PublicationYear 2017
SSID ssib002491397
ssib001054507
Score 2.1771355
SecondaryResourceType review_article
Snippet Peptides play a seminal role in most physiological processes acting as neurotransmitters, hormones, antibiotics, and immune regulation. In the context of tumor...
SourceID pubmed
SourceType Index Database
StartPage 27
Title The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome
URI https://www.ncbi.nlm.nih.gov/pubmed/29054270
Volume 42
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZ4LCwIxPslD2zIqEkcO2EDVIRARUiAxIbi2AaGplXJ0v567uw0CeUhYImiOHWbfF_t8_nuO0IOM8Vjw2XMUhsZxhMRsCxQEdMaptM0sCpzrovejbh84FeP8WMTq-qyS0p1nE--zCv5D6pwDXDFLNk_IFt3ChfgHPCFIyAMx19jfIthKXrQx_Jzfa8ge_rsEs57YBe7-vIlShKUozE7gylLux12r9E8qe1FND_PX0e5K-aFkQBIhlHTeduGxW_tFpNxK3fERe9U1VFclPxR7bq5zoZDn1EDj2Ea1-ndaxWIUif3VztUlQsikC0XhB-pwCZjsDCS7WHVi2ZNx0X55XDtPQfq7dgUEwyzk05O1YkelC38hn0HYJiCfRn6OiM_t85IaE-b5sm8TLC-x03LpQMGJv-g6cZRKdWl2U8fq0q2wrjAz78V5aSr_meWJs5EuV8hy9Xagp56oqySOVOskReAi9Y4UkcSOrAUSHJCkSL0M0XoLEXwA0AR2qII9RRpul4nDxfd-_NLVpXXYDmYbSXTMtQ8UIpLE8dRZmDuSq2MkijLYmsiMFwikdhcCaHgfqFxC51zlaQ65R0pRLhBFopBYbYIhTWwTjpSKms572SwSFW5UqFAMcGEq3SbbPoX8zT0GipP01e2823LLllquLZHFi38ac0-WIClOnAIvgNXCFXG
link.rule.ids 780
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Peptidome+Comes+of+Age%3A+Mass+Spectrometry-Based+Characterization+of+the+Circulating+Cancer+Peptidome&rft.jtitle=The+Enzymes&rft.au=Greening%2C+David+W&rft.au=Kapp%2C+Eugene+A&rft.au=Simpson%2C+Richard+J&rft.date=2017-01-01&rft.issn=0423-2607&rft.volume=42&rft.spage=27&rft_id=info:doi/10.1016%2Fbs.enz.2017.08.003&rft_id=info%3Apmid%2F29054270&rft_id=info%3Apmid%2F29054270&rft.externalDocID=29054270
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0423-2607&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0423-2607&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0423-2607&client=summon